Research Article | DOI: https://doi.org/10.31579/2640-1045/239
1Head of Marketing and Sales, Riggs Pharmaceuticals, Karachi; Department of Pharmacy, University of Karachi, Pakistan.
2Professor of Pharmaceutical Chemistry, Faculty of Pharmacy, SBB Dewan University, Karachi, Pakistan.
3Assistant Professor, Department of Pathology, Dow University of Health Sciences, Karachi, Pakistan.
4Assistant Professor, Department of Pathology, Dow University of Health Sciences, Karachi, Pakistan.
5GD Pharmaceutical Inc.; OPJS University, Rajasthan, India.
6Associate Professor, Department of Pathology, Dow University of Health Sciences, Karachi, Pakistan.
*Corresponding Author: Rehan Haider, Riggs Pharmaceuticals, Karachi; Department of Pharmacy, University of Karachi, Pakistan.
Citation: Rehan Haider, Shabana N. Shah, Zimmer Ahmed, China Abbas, Geetha K. Das, et al, (2026), Arthritis Associated with Sexually Transmitted Diseases: Pathogenesis, Clinical Features, and Management, J. Endocrinology and Disorders, 10(2); DOI:10.31579/2640-1045/239
Copyright: © 2026, Rehan Haider. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 10 March 2026 | Accepted: 17 March 2026 | Published: 20 April 2026
Keywords: reactive arthritis; sexually transmitted ailments; chlamydia trachomatis; neisseria gonorrhea; joint redness; hla-b27; reiter’s disease; catching arthritis; immunopathogenesis; antibiotic healing
The clinical entity of arthritis, which develops from sexually transmitted diseases (STDs), remains undiagnosed through multiple healthcare settings because it establishes a connection between infectious pathogens and inflammatory joint disorders. Among these, reactive arthritis and disseminated gonococcal infection are the most frequently reported conditions, particularly in sexually active young adults. The pathogens Chlamydia trachomatis and Neisseria gonorrhoeae, and the less common Treponema pallidum and human immunodeficiency virus (HIV), initiate an immune system response that results in joint inflammation.
The pathogenesis involves a complex interplay between microbial persistence, host immune response, and genetic susceptibility, particularly the presence of the HLA-B27 allele. The presentation of patients through clinical evaluation shows asymmetric oligoarthritis with urethritis and conjunctivitis, together with mucocutaneous symptoms, which create the classical triad of reactive arthritis. The medical presentation of disseminated gonococcal infection displays both polyarthralgia and tenosynovitis, together with skin lesions.
The diagnostic process requires multiple medical disciplines to work together through clinical assessment and laboratory research of infectious agents, analysis of synovial fluid, and advanced molecular testing. The medical situation requires immediate identification because it must stop joint damage and the rest of the body dysfunction, which develops through systemic issues.
The management strategies of this condition establish infection control through proper antimicrobial treatment while using anti-inflammatory medications, which include nonsteroidal anti-inflammatory drugs and corticosteroids. The treatment of persistent cases requires disease-modifying antirheumatic drugs as essential medication to control all severe symptoms.
Preventive measures, which include safe sexual practices and early screening and timely treatment of STDs, serve as essential tools for decreasing disease burden. Further research is needed to better understand immunopathogenesis and to develop targeted therapeutic strategies.
The condition of arthritis, which develops from sexually transmitted diseases (STDs), shows how infectious diseases affect rheumatology medical work. Young adults form the core of sexually active groups who experience STDs as a major public health issue because these infections produce systemic health problems that extend beyond their original infection sites. Inflammatory arthritis functions as an essential extra-genital symptom that develops when microorganisms enter the joint area or the body employs immune mechanisms to attack the joint.
The link between urethritis and arthritis has existed since ancient times, but medical professionals established its connection through the discovery of reactive arthritis during the early 20th century. Doctors used to identify reactive arthritis as Reiter's syndrome, which now exists as a type of sterile inflammatory arthritis that occurs because of gastrointestinal or genitourinary infections. Chlamydia trachomatis serves as the most common sexually transmitted pathogen that leads to infections, while Neisseria gonorrhoeae causes septic arthritis during disseminated gonococcal infections.
Multiple pathways lead to the development of STD-related arthritis, which includes both infectious agents and immune system responses. The body develops an abnormal immune response after a previous infection, which results in reactive arthritis, while bacteria enter the synovial tissues and produce gonococcal arthritis. The HLA-B27 allele serves as the main genetic factor that determines both disease susceptibility and the severity of disease symptoms.
Patients show a wide variety of symptoms, which can include acute monoarthritis, asymmetric oligoarthritis, and chronic polyarthritis [15]. Extra-articular manifestations occur commonly, and they can manifest as urethritis, conjunctivitis, and mucocutaneous lesions, which together create the classical triad of reactive arthritis [16,17]. The medical presentation of disseminated gonococcal infection includes three main symptoms, which are migratory polyarthralgia, tenosynovitis, and specific skin lesions [18].
To diagnose STD-related arthritis, doctors need to work together with their clinical skills and laboratory tests [19]. The diagnosis confirmation depends on the detection of causative pathogens through three techniques, which include nucleic acid amplification tests (NAATs), serological assays, and synovial fluid analysis [20,21]. The overlapping clinical features between infectious and reactive arthritis forms create challenges for medical professionals to differentiate these two types of joint inflammation [22].
The treatment approach aims to achieve two main objectives, which are to eliminate the base infection and to manage the resulting inflammation [23]. The main treatment method for infectious arthritis consists of antimicrobial therapy, while doctors use nonsteroidal anti-inflammatory drugs and corticosteroids to treat inflammatory symptoms [24]. In cases where the disease becomes chronic or does not respond to treatment, doctors will use disease-modifying antirheumatic drugs [25].
Health professionals must study the connection between sexually transmitted infections and arthritis because rising global rates of these infections now require early detection and proper treatment to stop long-term problems from developing.
Literature Review
The scientific literature provides extensive documentation about arthritis cases that occur because of sexually transmitted diseases (STDs), particularly in studies that focus on Chlamydia trachomatis and Neisseria gonorrhoeae infections [1,2]. Reactive arthritis, which belongs to the spondyloarthritis category, exists as the most common type of arthritis that results from Chlamydia trachomatis infections, which account for most post-infectious arthritis instances [3,4]. Studies show that between 1 and 4 percent of people who have untreated chlamydial infections will develop reactive arthritis [5].
The immune system of the body develops chronic inflammation because of persistent bacterial components that remain in the joint tissues of reactive arthritis patients [6]. The immune system triggers autoimmune disease development because bacterial peptides mimic human body proteins [7]. Research studies show that HLA-B27 increases both disease risk and disease severity across different human populations [8,9].
The STD-associated arthritis condition called disseminated gonococcal infection (DGI) typically develops through septic arthritis, tenosynovitis, and dermatitis presentations [10]. DGI establishes the need for immediate antimicrobial treatment because it leads to direct bacterial joint space invasion, which differs from the reactive arthritis condition [11]. Doctors need to diagnose the condition at an early stage because patients who receive their treatment later will experience permanent joint destruction [12].
The current research shows that other sexually transmitted pathogens, which include Treponema pallidum and HIV, cause inflammatory joint disorders [13,14]. HIV-associated arthritis usually develops as either acute or chronic polyarthritis, which resembles the symptoms of rheumatoid arthritis [15].
The existing research demonstrates that early diagnosis, together with specific antimicrobial treatment and proper treatment methods, will decrease illness rates while stopping permanent health issues [16].
The researchers investigated sexually transmitted disease-related arthritis using a narrative review approach.
The researchers conducted a comprehensive literature search using electronic databases, which included PubMed, Scopus, and Google Scholar. The search used the following keywords: "reactive arthritis," "sexually transmitted infections," "gonococcal arthritis," and "Chlamydia-associated arthritis." The researchers reviewed all articles published between 2000 and 2024.
Inclusion criteria:
Peer-reviewed journal articles
Studies focusing on STD-associated arthritis
English-language publications
Exclusion criteria:
Case reports with insufficient data.
Non-peer-reviewed articles
Duplicate studies
The researchers identified 85 articles through their initial search process, which led to a detailed screening of 40 articles. The researchers finally selected 25 high-quality studies, which they included in the final review.
The study conducted no primary statistical analysis because it operated as a narrative review. The researchers conducted qualitative analysis to study selected findings from various studies, which they then synthesized.
The study conducted descriptive comparisons to examine
Prevalence of reactive arthritis
Incidence of gonococcal arthritis
Association with HLA-B27
Treatment outcomes
The study presented percentages and relative risks from included studies to demonstrate clinical trends that were relevant to the research.
The results section shows that Chlamydia trachomatis leads to reactive arthritis development, which occurs most frequently in people between 18 and 40 years old, according to studies that researchers have conducted (17). The rate of reactive arthritis development after chlamydial infection shows a range between 1% and 4?cording to research (18).
Disseminated gonococcal infection accounts for a smaller but clinically significant proportion of septic arthritis cases, which especially affects sexually active people (19). The identified clinical features include the following common traits:
Asymmetric oligoarthritis
Urethritis
Conjunctivitis
Tenosynovitis
The study found that HLA-B27-positive individuals showed a genetic predisposition that led to more severe and longer-lasting health conditions (20).
| Feature | Reactive Arthritis (Chlamydia trachomatis) | Gonococcal Arthritis (Neisseria gonorrhoeae) | HIV-Associated Arthritis |
|---|---|---|---|
| Type of Arthritis | Sterile (immune-mediated) | Septic (infectious) | Inflammatory |
| Onset | 1–4 weeks post-infection | Acute | Variable |
| Joint Involvement | Asymmetric oligoarthritis | Monoarthritis or migratory | Polyarthritis |
| Common Age Group | Young adults (18–40 years) | Sexually active adults | All age groups |
| Extra-articular Features | Urethritis, conjunctivitis, skin lesions | Dermatitis, tenosynovitis | Skin & systemic features |
| Pathogenesis | Immune response to infection | Direct bacterial invasion | Immune dysregulation |
| HLA-B27 Association | Strong | Weak/None | Variable |
| Diagnosis | Clinical + NAATs | Culture + NAATs | Serology + clinical |
| Treatment | NSAIDs, antibiotics, DMARDs | Antibiotics (urgent) | Antiretroviral + NSAIDs |
| Prognosis | May become chronic | Good if treated early | Variable |
Table 1: Comparison of Major STD-Associated Arthritic Conditions
| Parameter | Reactive Arthritis (Chlamydia trachomatis) | Gonococcal Arthritis (Neisseria gonorrhoeae) | HIV-Associated Arthritis |
|---|---|---|---|
| Initial Clinical Suspicion | History of recent STD, urethritis, and conjunctivitis | Acute joint pain with fever, rash | Known HIV infection with joint symptoms |
| Key Symptoms | Asymmetric arthritis, enthesitis, and back pain | Monoarthritis, tenosynovitis, skin lesions | Symmetric or asymmetric polyarthritis |
| Laboratory Tests | NAAT for Chlamydia, ESR, CRP | Blood culture, synovial fluid culture, NAAT | HIV serology, CD4 count, viral load |
| Synovial Fluid Findings | Sterile (no bacteria) | Purulent, bacteria present | Inflammatory, sterile |
| Imaging | Mild joint inflammation | Joint effusion, possible damage | Variable joint changes |
| First-Line Treatment | NSAIDs + antibiotics (if active infection) | IV/IM antibiotics (ceftriaxone) | Antiretroviral therapy + NSAIDs |
| Second-Line Treatment | Corticosteroids, DMARDs | Joint drainage if needed | DMARDs (in selected cases) |
| Duration of Therapy | Weeks to months | 7–14 days (antibiotics) | Long-term management |
| Complications | Chronic arthritis, relapse | Joint destruction if delayed | Chronic inflammatory arthritis |
| Prevention | Safe sex, early STD treatment | STD screening & treatment | HIV control & monitoring |
Table 2: Diagnostic Approach and Management of STD-Associated Arthritis

Figure 1: Pathogenesis of STD-Associated Arthritis
Source: Created by Haider et al 2026

Source: Created by Haider et al 2026
Figure 2: Clinical Presentation and Diagnostic Workflow of STD-Associated Arthritis



Figure 3: Treatment Algorithm for Arthritis Associated with Sexually Transmitted Diseases
Source: Created by Haider et al 2026
The findings of this review reinforce the strong association between sexually transmitted infections and inflammatory joint diseases. Reactive arthritis remains the most prevalent form, primarily triggered by Chlamydia trachomatis, while Neisseria gonorrhoeae is responsible for septic arthritis through direct joint infection (22).
The role of immune mechanisms, including molecular mimicry and persistent antigen stimulation, highlights the complexity of disease pathogenesis (23). The association with HLA-B27 further underscores the importance of genetic factors in disease susceptibility and progression (24).
Clinically, the overlap between infectious and autoimmune arthritis presents a diagnostic challenge, often leading to delayed treatment. This emphasizes the need for improved screening strategies and clinician awareness (25).
Early intervention with appropriate antimicrobial and anti-inflammatory therapy significantly improves outcomes and reduces the risk of chronic disability.
Arthritis associated with sexually transmitted diseases is an important but often under-recognized clinical condition. Reactive arthritis and gonococcal arthritis are the most common manifestations, with significant implications for patient health.
Early diagnosis, appropriate antimicrobial therapy, and effective management of inflammation are essential to prevent long-term complications. Increased awareness, routine screening, and preventive strategies such as safe sexual practices are crucial in reducing disease burden.
Further research is needed to better understand immunopathological mechanisms and to develop targeted therapeutic approaches.
Acknowledgment:
The completion of this research assignment would not have been possible without the contributions and assistance of many individuals and groups. We’re. Deeply thankful to all those who played a role in the success of this project, I would like to thank My Mentor, Dr.Naweed Imam Syed, Professor, Department of Cell Biology at the University of Calgary, for their useful input and guidance for the duration of the research project. Their insights and understanding had been instrumental in shaping the path of this undertaking.
Authors ‘Contribution
I would like to increase our sincere way to all the members of our study, who generously shared their time, studies, and insights with us. Their willingness to interact with our studies became essential to the success of this assignment, and we’re deeply thankful for their participation.
Conflict of Interest:
The authors declare no conflict of interest.
Funding and Financial Support:
The authors received no financial support for the research, authorship, and/or publication of this
Dear Editorial Team, Clinical Medical Reviews and Reports. My experience with the journal was highly positive. The peer-review process was rigorous, constructive, and completed in a timely manner. The reviewers provided valuable comments that helped improve the quality and clarity of our manuscript. The editorial office was professional, responsive, and supportive throughout all stages of the publication process. Communication was clear and efficient, and any questions were addressed promptly. Overall, I found the journal to maintain high scientific standards and an excellent publication workflow. I would be pleased to consider submitting future work to this journal. Best wishes from, Elena Popa.
It was my pleasure to submit my testimonial concerning the Reviewer Board of our Scientific Journal “Brain and Neurological Disorders”. The Reviewers focused on some modifications and their contribution was helpful. The ladies of our Editorial Office were also supported my efforts. It was my honor to have such a co-operation and I am looking forward for more collaboration.
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Thank you for the speedy and efficient peer review process. I appreciate the fact that your peer reviewers do not take months to respond like with some other journals. I would also like to thank the editorial office for responding quickly to my questions. It is an excellent journal. I plan to submit more manuscripts in the future. Best wishes from, Robert W. McGee
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Working with you and your team on our recent publication in JCRR has been a truly wonderful and enjoyable experience. The responses were prompt, and the reviewers were patient, constructive, and highly professional. One reviewer in particular gave me the feeling that a professor was carefully reading and commenting on my coursework, which was deeply touching. The entire process was straightforward and hassle‑free, with no tedious online forms to complete. I highly recommend this journal. Best wishes from, DR Aibing Rao, Head of R&D
I Appreciate the Opportunity to Share my Experience with the Journal of Clinical Research and Reports. The peer review process was timely and constructive, and the feedback provided helped improve the quality of our manuscript. The editorial office was professional, responsive, and supportive throughout the process, ensuring smooth communication and efficient handling of the submission. Overall, it was a positive experience collaborating with your team.
Dear Mercy Grace, Editorial Coordinator of Obstetrics Gynecology and Reproductive Sciences, We would like to express our gratitude for your help at all stages of publishing and editing the article. The editors of the magazine answer all the necessary questions and help at every stage. We will definitely continue to cooperate and publish other works in the Obstetrics Gynecology and Reproductive Sciences! Best wishes from, Alla Konstantinovna Politova,